Optimal Perioperative Fluid Therapy Associates with Fewer Complications After Pancreaticoduodenectomy

por Peltoniemi, Piia, Pere, Pertti, Mustonen, Harri, Seppänen, Hanna
Publicado 2022

Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study

por Johansson, Katarina, Mustonen, Harri, Seppänen, Hanna, Lehtimäki, Tiina E.
Publicado 2022

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer

por Lanki, Mira, Seppänen, Hanna, Mustonen, Harri, Hagström, Jaana, Haglund, Caj
Publicado 2019

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy

por Nurmi, Anna Maria, Hagström, Jaana, Mustonen, Harri, Seppänen, Hanna, Haglund, Caj
Publicado 2022

Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis

por Saraswat, Mayank, Joenväärä, Sakari, Seppänen, Hanna, Mustonen, Harri, Haglund, Caj, Renkonen, Risto
Publicado 2017

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma

por Mattila, Nora, Seppänen, Hanna, Mustonen, Harri, Przybyla, Beata, Haglund, Caj, Lassila, Riitta
Publicado 2018

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer

por Eurola, Annika, Mustonen, Harri, Mattila, Nora, Lassila, Riitta, Haglund, Caj, Seppänen, Hanna
Publicado 2022

MRI follow-up for pancreatic intraductal papillary mucinous neoplasm: an ultrashort versus long protocol

por Johansson, Katarina, Mustonen, Harri, Nieminen, Heini, Haglund, Caj, Lehtimäki, Tiina E., Seppänen, Hanna
Publicado 2021

Use of self-expandable metallic stents for endoscopic biliary decompression decreases stent complications in pancreatic cancer patients receiving chemotherapy

por Vehviläinen, Sini, Seppänen, Hanna, Nurmi, Anna, Haglund, Caj, Mustonen, Harri, Udd, Marianne, Kylänpää, Leena
Publicado 2021

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma

por Kaasinen, Mirjami, Hagström, Jaana, Mustonen, Harri, Sorsa, Timo, Sund, Malin, Haglund, Caj, Seppänen, Hanna
Publicado 2022

The possible dual role of Ang-2 in the prognosis of pancreatic cancer

por Roos-Mattila, Matilda, Kaprio, Tuomas, Mustonen, Harri, Hagström, Jaana, Saharinen, Pipsa, Haglund, Caj, Seppänen, Hanna
Publicado 2023

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

por Salmiheimo, Aino, Mustonen, Harri, Stenman, Ulf-Håkan, Puolakkainen, Pauli, Kemppainen, Esko, Seppänen, Hanna, Haglund, Caj
Publicado 2016

Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma

por Nurmi, Anna M., Mustonen, Harri K., Stenman, Ulf-Håkan, Seppänen, Hanna E., Haglund, Caj H.
Publicado 2021

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer

por Eurola, Annika, Ristimäki, Ari, Mustonen, Harri, Nurmi, Anna-Maria, Hagström, Jaana, Haglund, Caj, Seppänen, Hanna
Publicado 2021

Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma

por Korpela, Taija, Ristimäki, Ari, Udd, Marianne, Vuorela, Tiina, Mustonen, Harri, Haglund, Caj, Kylänpää, Leena, Seppänen, Hanna
Publicado 2022

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

por Mäkinen, Lotta, Vähä-Koskela, Markus, Juusola, Matilda, Mustonen, Harri, Wennerberg, Krister, Hagström, Jaana, Puolakkainen, Pauli, Seppänen, Hanna
Publicado 2022

Pancreatic cancer survival prediction via inflammatory serum markers

por Lanki, Mira, Seppänen, Hanna, Mustonen, Harri, Salmiheimo, Aino, Stenman, Ulf-Håkan, Salmi, Marko, Jalkanen, Sirpa, Haglund, Caj
Publicado 2022

aMMP-8 POCT for Periodontal Disease: An Indicator of Poor Oral Health

por Gupta, Shipra, Räisänen, Ismo T., Seppänen, Hanna, Hagström, Jaana, Grigoriadis, Andreas, Hermunen, Kethe, Sakellari, Dimitra, Haglund, Caj, Sorsa, Timo
Publicado 2023

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

por Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Fermér, Christian, Nilsson, Olle, Seppänen, Hanna, Haglund, Caj
Publicado 2015

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

por Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Juuti, Anne, Nordling, Stig, Kallio, Pauliina, Alitalo, Kari, Seppänen, Hanna, Haglund, Caj
Publicado 2016